Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion type Assertion NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_head.
- NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion description "[As a result, we found that the mRNA levels of FCMR in the CLL patients are 23-fold higher than that of the control group and this may suggest that it can be associated with the disease progression and survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_provenance.
- NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion evidence source_evidence_literature NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_provenance.
- NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion SIO_000772 21264533 NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_provenance.
- NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion wasDerivedFrom befree-20150227 NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_provenance.
- NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_assertion wasGeneratedBy ECO_0000203 NP817913.RApuEiXDKY2jyr0hRwBMBIj6Ic3zQ1UQh9fQ_HqFaBPWw130_provenance.